NCT03313297
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Leeds Teaching Hospitals Trust Leeds, United Kingdom
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
155 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT03877523
- Conditions
- Diabetes Complications, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Institute for Atherosclerosis Research Moscow, Russia
NCT02748330
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT01620489
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Concord, California, United States
- Novo Nordisk Investigational Site La Jolla, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Monterey, California, United States
NCT02470039
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Mainz, Germany
- Novo Nordisk Investigational Site Neuss, Germany
NCT03138447
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
- MODEL Clinical Research Towson, Maryland, United States
NCT02423850
- Conditions
- Autoimmune Diseases, Cardiovascular Diseases, Diabetes Complications, +17 more
- Locations
-
- University Centre of Wound Healing, Odense University Hospital (OUH) Odense, Denmark
NCT02306681
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Dhaka, Bangladesh
- Novo Nordisk Investigational Site Bogotá, Colombia
- Novo Nordisk Investigational Site Cairo, Egypt
- Novo Nordisk Investigational Site Manila, Philippines
Completed
The Effects of LY2409021 on the Liver
NCT01588366
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore
NCT01729130
- Conditions
- Autoimmune Diseases, Chronic Disease, Diabetes Mellitus, +20 more
- Locations
-
- The University of Texas Medical Branch (UTMB) Galveston, Texas, United States